Export 118 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is W  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
Z. Wu, Tang, Z., Mao, Y., Van Veldhuisen, P., Ling, W., Liu, D., Shen, Z., Detels, R., Lan, G., Erinoff, L., Lindblad, R., Gu, D., Tang, H., Hu, L., Zhu, Q., Lu, L., Oden, N., Hasson, A. L., Zhao, Y., McGoogan, J. M., Ge, X., Zhang, N., Rou, K., Zhu, J., Wei, H., Shi, C. X., Jin, X., Li, J., and Montaner, J. S. G., Testing and linkage to HIV care in China: a cluster-randomised trial., Lancet HIV, vol. 4, no. 12, pp. e555-e565, 2017.
L. - T. Wu, McNeely, J., Subramaniam, G. A., Brady, K. T., Sharma, G., VanVeldhuisen, P., Zhu, H., and Schwartz, R. P., DSM-5 substance use disorders among adult primary care patients: Results from a multisite study., Drug Alcohol Depend, vol. 179, pp. 42-46, 2017.
L. - T. Wu, John, W. S., Ghitza, U. E., Wahle, A., Matthews, A. G., Lewis, M., Hart, B., Hubbard, Z., Bowlby, L. A., Greenblatt, L. H., and Mannelli, P., Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network., Addiction, 2021.
L. - T. Wu, McNeely, J., Subramaniam, G. A., Sharma, G., VanVeldhuisen, P., and Schwartz, R. P., Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool., Contemp Clin Trials, vol. 50, pp. 90-7, 2016.
L. Wu, Ghitza, U. E., Lewis, M., Matthews, A. G., and Mannelli, P., Design of the Buprenorphine Physician-Pharmacist Collaborative Care of Patients with Opioid Use Disorder. , in 81st Annual Scientific Meeting of the College of Problems on Drug Disorders (CPDD), , San Antonio, TX. , 2019.
L. - T. Wu, Brady, K. T., Spratt, S. E., Dunham, A. A., Heidenfelder, B., Batch, B. C., Lindblad, R., VanVeldhuisen, P., Rusincovitch, S. A., Killeen, T. K., and Ghitza, U. E., Using electronic health record data for substance use Screening, Brief Intervention, and Referral to Treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study., Contemp Clin Trials, vol. 46, pp. 30-38, 2016.
D. E. Bonds, Harrington, M., Worrall, B. B., Bertoni, A. G., Eaton, C. B., Hsia, J., Robinson, J., Clemons, T. E., Fine, L. J., and Chew, E. Y., Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial., JAMA Intern Med, vol. 174, no. 5, pp. 763-71, 2014.
A. Domalpally, Clemons, T. E., Danis, R. P., Sadda, S. V. R., Cukras, C. A., Toth, C. A., Friberg, T. R., and Chew, E. Y., Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research G, Ophthalmology, vol. 124, no. 4, pp. 479-487, 2017.
P. F. Wright, Mestecky, J., M McElrath, J., Keefer, M. C., Gorse, G. J., Goepfert, P. A., Moldoveanu, Z., Schwartz, D., Spearman, P. W., Habib, R. El, Spring, M. D., Zhu, Y., Smith, C., Flores, J., and Weinhold, K. J., Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein., J Infect Dis, vol. 189, no. 7, pp. 1221-31, 2004.
B. L. Wright, Kulis, M., Orgel, K. A., Burks, A. W., Dawson, P., Henning, A. K., Jones, S. M., Wood, R. A., Sicherer, S. H., Lindblad, R. W., Stablein, D., Leung, D. Y. M., Vickery, B. P., and Sampson, H. A., Component-resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness., Allergy, vol. 71, no. 11, pp. 1552-1560, 2016.
M. Wright, Lindblad, R., Jelstrom, E., King, D., Blumberg, D., Yohannes, P., Yesko, L., Campanella, M., and Saunders, C. A., Implementation of a Medication and Supply Inventory and Resupply Process - Increasing the Efficiency of the Tracking and Distribution of Supplies in Clinical Trials, in Society for Clinical Trials (SCT) 36th Annual Meeting (2015), Arlington, VA, 2015.
J. Wright, Blatner, G. L., and Cheson, B. D., Clinical trials referral resource. Clinical trials with the farnesyl transferase inhibitor R115777., Oncology (Williston Park), vol. 13, no. 11, p. 1527, 1530, 1533, 1999.
P. F. Wright, Lambert, J. S., Gorse, G. J., Hsieh, R. H., McElrath, M. J., Weinhold, K., Wara, D. W., Anderson, E. L., Keefer, M. C., Jackson, S., Wagner, L. J., Francis, D. P., Fast, P. E., and McNamara, J., Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women., J Infect Dis, vol. 180, no. 4, pp. 1080-8, 1999.
J. J. Wright, Blatner, G., and Cheson, B. D., Clinical trials referral resource. Clinical trials of dolastatin-10., Oncology (Williston Park), vol. 13, no. 1, pp. 68-70, 75, 1999.
J. Wright, Hillsamer, V. L., Gore-Langton, R. E., and Cheson, B. D., Clinical trials referral resource. Current clinical trials for the proteosome inhibitor PS-341, Oncology, vol. 14, pp. 1589-15901593-94 1597, 2000.
J. J. Wright, Zerivitz, K., and Schoenfeldt, M., Clinical trials referral resource. Current clinical trials of bortezomib., Oncology (Williston Park), vol. 17, no. 5, pp. 677-80, 683-6, 691-2, 2003.
P. F. Wright, Lambert, J. S., Gorse, G. J., Hsieh, R. H., McElrath, M. J., Weinhold, K., Ware, D. W., Anderson, E. L., Keefer, M. C., Jackson, S., Wagner, L. J., Francis, D. P., Fast, P. E., McNamara, J., and Group, A. I. D. S. Vaccine Ev, Immunization with envelope MN rap 120 vaccine in human immunodeficiency virus infected pregnant women, J Infec Dis, vol. 180, pp. 1080-8, 1999.
J. J. Wright, Zerivitz, K., Gravell, A. E., and Cheson, B. D., Clinical trials referral resource. Current clinical trials of R115777 (Zarnestra)., Oncology (Williston Park), vol. 16, no. 7, pp. 930-1, 935-7, 2002.
J. Wright, Blatner, G. L., and Cheson, B. D., Clinical trials referral resource. Clinical trials of flavopiridol., Oncology (Williston Park), vol. 12, no. 7, pp. 1018, 1023-4, 1998.
J. Wright, Hillsamer, V. L., Gore-Langton, R. E., and Cheson, B. D., Clinical trials referral resource. Current clinical trials for the proteasome inhibitor PS-341., Oncology (Williston Park), vol. 14, no. 11, pp. 1589-90, 1593-4, 1597, 2000.
C. W. Woods, Sanchez, A. M., Swamy, G. K., McClain, M. T., Harrington, L., Freeman, D., Poore, E. A., Slifka, D. K., DeRaad, D. E. Poer, Amanna, I. J., Slifka, M. K., Cai, S., Shahamatdar, V., Wierzbicki, M. R., Amegashie, C., and Walter, E. B., An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults., Vaccine, vol. 37, no. 30, pp. 4222-4230, 2019.
E. Woodle, Van Veldhuisen, P., and , A Prospective, Randomized, Multicenter, Double-Blind Study of Early Corticosteroid Cessation Versus Long-Term Maintenance of Corticosteroid Therapy with Tacrolimus and Mycophenolate Mofetil in Primary Renal Transplant Recipients: One Year Report, Transplant Proc, vol. 37, pp. 804-808, 2005.
S. Woodle, First, M. R., Pirsch, J., Shihab, F., Gaber, A. O., and P Van Veldhuisen, forthe Astell, A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation Versus Long-Term, Low-Dose Corticosteroid Therapy, Ann Surg, vol. 248, pp. 564-577, 2008.
E. S. Woodle, Cincinnati, Dof Transpl, and Group, F. Steroid Wi, A Randomized, Double Blind, Placebo Controlled Trial of Early Corticosteroid Cessation vs Chronic Corticosteroid Maintenance Therapy, in American Transplant Congress (ATC), Philadelphia, PA, 2005.
S. E Woodle, M First, R., Pirsch, J., Shihab, F., A Gaber, O., and Van Veldhuisen, P., A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy., Ann Surg, vol. 248, no. 4, pp. 564-77, 2008.